2024. THE DIRECT AND INDIRECT COST OF HEPATITIS B AND C VIRUS REALTED DISEASES: EVIDENCE FROM PAKISTAN. The Research of Medical Science Review. 2, 3 (Dec. 2024), 1121–1132.